Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

MSP Recovery to go public via nearly $33 billion mega SPAC deal

Published 07/12/2021, 02:29 AM
Updated 07/12/2021, 10:31 AM
© Reuters. FILE PHOTO: A photo illustration shows a stethoscope and  blood-pressure machine of a French general practitioner displayed in a doctor's office January 7, 2015.   REUTERS/Regis Duvignau

By Noor Zainab Hussain

(Reuters) - MSP Recovery, which helps recover money from Medicare and Medicaid secondary payments, will go public through a deal with a blank-check firm, giving the combined company an enterprise value of $32.6 billion in the second biggest SPAC merger.

The deal with Lionheart Acquisition Corp II is expected to fetch $230 million in proceeds for MSP, it said on Monday. https://refini.tv/3wuAoOV

MSP, led by billionaire entrepreneur John Ruiz, collects and analyzes data on the government-backed Medicare and Medicaid insurance claims, and then helps recover money owed to its clients, which include hospitals, health insurers and medical providers.

"Medicare and Medicaid pay billions of dollars of healthcare claims they should not pay. This harms taxpayers, the underprivileged, and America's senior citizens," Ruiz said.

"Our tools help fix this broken system."

Medicare Advantage plans cater to Americans older than 65 and those with disabilities.

The Florida-based company, founded in 2014, earns a fee after a successful recovery. The Lionheart deal will help MSP quickly buy claims portfolios, while further growing its data-analytics capabilities, it said.

Special purpose acquisition companies, or SPACs, are shell companies that raise funds through an initial public offering to take a private company public through a merger at a later date.

Lionheart raised $230 million in an initial public offering in August. The company's shares were up 5.2% at $10.40 in trading before the bell.

At $32.6 billion, the merger is second in size only to the nearly $40 billion deal inked in April between Southeast Asia's Grab and Altimeter Growth Corp.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The MSP deal is also the largest since the U.S. Securities and Exchange Commission said it was considering new rules to protect investors amid a surge in the use of SPACs as capital-raising vehicles.

It also pointed to a rebound in merger activity in the blank-check space after Wall Street's appetite showed signs of waning following a period of frenetic deal-making using the investment vehicle.

In the past few months, biotech company Ginkgo Bioworks and SoftBank-backed mortgage startup Better HoldCo have announced multi-billion dollar deals with blank-check vehicles.

Lionheart stockholders who do not redeem shares of its common stock will be issued more than 1 billion warrants in connection with the merger, the company said.

MSP's founders will sell an equivalent number of their shares back to the company so that the provision won't dilute the stock's value.

MSP will list its stock on Nasdaq under the ticker symbol "MSPR". Its existing and additional warrants will trade as "LCAP W", and "MSPR W", respectively.

Keefe, Bruyette & Woods served as the financial adviser to MSP, while Nomura Securities advised Lionheart.

The deal is expected to be completed in the fourth quarter of 2021.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.